Introduction
============

This research project was motivated by our interest in devising a direct and versatile strategy for stereoselectively assembling chiral annulated furans.[@cit1] As shown in [Fig. 1](#fig1){ref-type="fig"}, many biologically active compounds and natural products possess a furan system fused to rings of various sizes and adorned with multiple stereocenters.[@cit2] Despite significant advances in preparing racemic 2,3-furan-fused carbocycles,[@cit3] there are only a few catalytic strategies for their direct stereoselective synthesis.[@cit4]

![Naturally occurring chiral annulated furans.](c5sc01052g-f1){#fig1}

Herein, we describe a straightforward synthetic strategy for accessing six- and seven-membered-ring furan derivatives bearing adjacent quaternary and tertiary carbon stereocentres in very high yields and stereoselectivities. The chemistry, which uses readily available substrates and catalysts, is based on a two-step sequential process whereby an organocatalytic asymmetric addition of β-ketoesters **2** to cyclic 2-(1-alkynyl)-2-alkene-1-ones **1** ([@cit5]) is followed by a silver-catalysed intramolecular cycloisomerisation of the transient allenyl ketone[@cit7] intermediate **3** ([Scheme 1](#sch1){ref-type="fig"}). Significantly, we have identified two distinct catalytic systems which infer complementary diastereoselectivities, thereby enabling access to the full complement of stereoisomers of the annulated products **4** and **5** at will.[@cit8]

![Diastereodivergent and enantioselective synthesis of chiral 2,3-furan fused carbocycles *via* an organocatalytic 4,5′-addition/cycloisomerisation sequence promoted by distinct organocatalysts (Cat A & Cat B) and a silver catalyst, respectively.](c5sc01052g-s1){#sch1}

Results and discussion
======================

Our initial explorations focused on the reaction between 2-phenylethynyl-2-cyclohexen-1-one **1a** ([@cit9]) and the cyclic ketoester **2a** in DCM and in the presence of 5 mol% of a chiral tertiary amine, which could act as a general base catalyst (deprotonative activation of **2a**). The process was conducted in two sequential steps, with the initial organocatalytic path exclusively providing the corresponding allenyl ketone of type **3** ([@cit10]) ([Scheme 1](#sch1){ref-type="fig"}) by means of a selective 4,5′-addition.[@cit6] Upon filtering out the chiral amine through SiO~2~ and evaporation of the solvent, the cycloisomerisation of crude **3a** was achieved by applying a slightly modified Marshall procedure[@cit7],[@cit11] (using 10 mol% AgNO~3~, and AcOEt at 40 °C) to afford the diastereomeric adducts **4** and **5**.

We focused on identifying chiral organocatalysts that could infer high stereocontrol in the initial 4,5′-addition reaction. Representative results of our extensive studies are listed in [Table 1](#tab1){ref-type="table"}, with more details reported in the ESI.[†](#fn1){ref-type="fn"} Intriguingly, natural cinchona alkaloid derivatives,[@cit12] acting as general base catalysts,[@cit13] afforded impressive levels of stereoselectivity (**4a** formed with a dr of up to 19 : 1, and an ee of up to 99%, entries 1--4), largely outperforming any other synthetic catalyst tested (see ESI[†](#fn1){ref-type="fn"}).

###### Selected optimisation studies on the model reaction[^*a*^](#tab1fna){ref-type="fn"}

  ![](c5sc01052g-u1.jpg){#ugr1}                                                                                    
  ----------------------------------------------------------------------------------- ------------ ----- --------- ----------------
  1                                                                                   **QN**       66    19 : 1    99 (1*R*,2*R*)
  2                                                                                   **CD**       62    12 : 1    99 (1*R*,2*R*)
  3                                                                                   **QD**       82    18 : 1    98 (1*S*,2*S*)
  4                                                                                   **CN**       84    17 : 1    98 (1*S*,2*S*)
  5[^*e*^](#tab1fne){ref-type="table-fn"}                                             **QN**       83    19 : 1    99 (1*R*,2*R*)
  6                                                                                   OMe-**QN**   15    1 : 1.5   \<5
  7                                                                                   **QN-OH**    \<5   ---       ---
  8[^*f*^](#tab1fnf){ref-type="table-fn"} ^,^[^*g*^](#tab1fng){ref-type="table-fn"}   **PTC-QN**   73    1 : 13    86 (1*R*,2*S*)
  9[^*f*^](#tab1fnf){ref-type="table-fn"}                                             **PTC-QD**   89    1 : 19    87 (1*S*,2*R*)

^*a*^Reactions were performed in DCM at --10 °C on a 0.2 mmol scale using 1.2 equiv. of **2a**, with \[**1a**\]~0~ = 0.1 M. After 48 hours, the 4,5′-addition was quenched by filtration through a pad of silica. Upon evaporation of the solvent, the cycloisomerisation of the intermediate **3a** was conducted by dissolving the crude residue in 2 mL of AcOEt and adding 10 mol% of AgNO~3~.

^*b*^Yield of the isolated products **4a** and **5a** (diastereomeric mixture).

^*c*^Diastereomeric ratio determined by ^1^H NMR analysis of the crude mixture upon cycloisomerisation.

^*d*^Enantiomeric excess, as determined by HPLC analysis on chiral stationary phases, refers to the major diastereoisomer; the absolute configuration is specified between brackets.

^*e*^\[**1a**\]~0~ = 0.5 M.

^*f*^Performed at --20 °C in a 5 : 1 mixture of DCM/33% K~2~CO~3~ aq., with \[**1a**\]~0~ = 0.2 M.

^*g*^Performed using 10 mol% of catalyst.

Importantly, the use of the "pseudoenantiomeric" catalysts quinine (**QN**) and quinidine (**QD**) secured access to both antipodes of the adduct **4** with excellent selectivity (entries 5 & 3, respectively). Protection of the quinine hydroxy moiety resulted in a greatly reduced reactivity along with a complete loss of stereocontrol (entry 6). Mechanistically, this suggests that the cinchona catalysts might operate through a bifunctional activation mode, simultaneously binding and activating the two reacting partners.[@cit13a],[@cit14] Interestingly, the cupreidine derivative **QN-OH**, a catalyst with a proven ability to promote the highly stereoselective addition of β-ketoesters to cyclic enones, remained completely inactive in our system (entry 7).[@cit15]

We then modified the cinchona alkaloid scaffold by alkylating the basic bridgehead nitrogen of the quinuclidine core, the classical approach for achieving catalysts suitable for use as phase transfer catalysts (PTCs).[@cit16] Among the many PTCs tested in the model reaction (see ESI[†](#fn1){ref-type="fn"} for details), the cinchona-derived trimeric species **PTC-QN** and **PTC-QD**,[@cit17] easily obtained by the poly-alkylation of quinine and quinidine with 1,3,5-tris(bromomethyl)benzene, provided the most interesting results. When performing the reaction in DCM and in the presence of 33% K~2~CO~3~ aq., a complete switch of the enforced sense of diastereoinduction was achieved, so that the adduct **5** was almost exclusively formed in high optical purity (entries 8 & 9).

These findings allowed us to fully control the stereochemical outcome of the process, enabling the generation of any stereoisomer of the annulated furans **4** and **5** at will. This is considered a challenging goal because when asymmetric catalysis is applied to processes that generate two stereogenic centres in one product, there is generally no obvious means of modifying a catalyst to modulate the relative sense of those two centres.[@cit8] In this case, the two diastereodivergent systems are based on different organocatalysts, but are derived from the common chiral core of natural cinchona alkaloids. The divergent stereocontrol arises from the ability of the cinchona catalysts to execute distinct modes of catalysis for activating the reagents (base catalysis *vs.* phase transfer catalysis, [Scheme 2](#sch2){ref-type="fig"}).

![Accessing the full matrix of the stereoisomers of the annulated furans **4a** and **5a**. When **QN** and **QD** function as general base catalysts, both enantiomers of the diastereoisomer **4a** could be accessed. Modifying the catalyst structure to induce a different activation pattern, namely phase transfer catalysis, enables direct access to both antipodes of **5a** using **PTC-QN** and **PTC-QD**.](c5sc01052g-s2){#sch2}

Having identified two distinct catalytic systems that can selectively channel the reaction manifolds toward complementary diastereochemical outcomes, we examined the scope of the two-step process using **QN** (5 mol%) as a general base catalyst. As revealed in [Table 2](#tab2){ref-type="table"}, the method shows a wide substrate generality and an excellent level of stereoselectivity, providing access to a variety of complex annulated furans **4** adorned with two vicinal quaternary and tertiary stereocentres. We first tested the possibility of modifying the cyclic scaffold of the 2-(1-alkynyl)-2-alken-1-one component **1**. The cycloheptenone derivative reacted smoothly to provide the seven-membered-ring furan **4b** in high optical purity (entry 2). In contrast, the cyclopentenone derivative was not a suitable substrate, since a complete lack of reactivity in the silver-catalysed intramolecular cycloisomerisation step was observed. Different substitution patterns on the aromatic moiety of **1** were well-tolerated, regardless of their electronic properties (entries 3--5). In addition, an alkyne bearing a vinylic substituent (entry 6) provided the corresponding furan **4f** with high stereocontrol, albeit with a moderate chemical yield. A limitation of the system is that we have thus far failed to react alkynes bearing alkyl or TMS groups, and linear substrates.

###### Synthesis of chiral annulated furans by general base catalysis: nucleophile and electrophile scope[^*a*^](#tab2fna){ref-type="fn"}

  ![](c5sc01052g-u2.jpg){#ugr2}                                                                                                            
  ------------------------------- ------------------------------- ----- ----- ---------------------------------------------- ---- -------- ----
  1                               Ph, 1                           H     H     **a**                                          83   19 : 1   99
  2                               Ph, 2                           H     H     **b**                                          75   12 : 1   97
  3                               4-MeOC~6~H~4~, 1                H     H     **c**                                          83   19 : 1   99
  4                               4-CF~3~C~6~H~4~, 1              H     H     **d**                                          90   19 : 1   99
  5                               4-MeC~6~H~4~, 1                 H     H     **e**                                          83   19 : 1   99
  6                               ![](c5sc01052g-u3.jpg){#ugr3}   H     H     **f**                                          25   19 : 1   95
  7                               Ph, 1                           MeO   H     **g**                                          62   19 : 1   99
  8                               Ph, 1                           H     Br    **h** [^*e*^](#tab2fne){ref-type="table-fn"}   82   19 : 1   98
  9                               Ph, 1                           MeO   MeO   **i**                                          67   19 : 1   99
  10                              Ph, 1                           H     Me    **j**                                          87   19 : 1   97
  11                              Ph, 1                           F     H     **k**                                          88   19 : 1   98

^*a*^Reactions were performed at --10 °C on a 0.2 mmol scale and using 1.2 equiv. of **2**. After 48 hours, the organocatalytic 4,5′-addition was quenched by filtration through a pad of silica. Upon evaporation of the solvent, the crude residue was dissolved in 2 mL of AcOEt and 10 mol% of AgNO~3~ was added.

^*b*^Yield of the isolated products **4** (diastereomeric mixture).

^*c*^Diastereomeric ratio determined by ^1^H NMR analysis of the crude mixture upon cycloisomerization.

^*d*^Enantiomeric excess determined by HPLC analysis on chiral stationary phases.

^*e*^The absolute configuration of **4h** was unambiguously inferred by X-ray analysis, see [@cit18].

As for the nucleophilic partners **2**, electronic variations in the indanone ring were possible, as both electron donating and withdrawing substituents gave the desired products in high yields and excellent diastereo- and enantioselectivities (entries 7--11). Efforts to react six-membered cyclic and linear β-ketoesters need further optimization, since only traces of the corresponding products could be obtained.

We then evaluated the synthetic potential of the PTC-mediated system. As depicted in [Table 3](#tab3){ref-type="table"}, the reactions catalysed by 5 mol% of **PTC-QD** showed a comparable versatility to the system under general base catalysis, but secured a complementary diastereoselectivity, since the opposite diastereoisomers **5** of the annulated furans were almost exclusively formed with high enantiocontrol.

###### Synthesis of chiral annulated furans under PTC conditions: nucleophile and electrophile scope[^*a*^](#tab3fna){ref-type="fn"}

  ![](c5sc01052g-u4.jpg){#ugr4}                                                                                
  ----------------------------------------- ------------------------------- ----- ----- ------- ---- --------- ----
  1[^*e*^](#tab3fne){ref-type="table-fn"}   Ph, 1                           H     H     **a**   89   19 : 1    87
  2                                         Ph, 2                           H     H     **b**   81   9.5 : 1   93
  3                                         4-MeOC~6~H~4~, 1                H     H     **c**   87   19 : 1    89
  4                                         4-CF~3~C~6~H~4~, 1              H     H     **d**   84   8 : 1     81
  5                                         4-MeC~6~H~4~, 1                 H     H     **e**   82   19 : 1    91
  6[^*f*^](#tab3fnf){ref-type="table-fn"}   ![](c5sc01052g-u5.jpg){#ugr5}   H     H     **f**   53   19 : 1    92
  7[^*f*^](#tab3fnf){ref-type="table-fn"}   Ph, 1                           MeO   MeO   **i**   62   16 : 1    72
  8[^*f*^](#tab3fnf){ref-type="table-fn"}   Ph, 1                           H     Br    **h**   78   11 : 1    77
  9                                         Ph, 1                           H     Me    **j**   87   19 : 1    87
  10                                        Ph, 1                           F     H     **k**   87   15 : 1    85
  11                                        Ph, 1                           Br    H     **l**   70   19 : 1    83

^*a*^Reactions were performed at --20 °C in a 5 : 1 mixture of DCM/33% K~2~CO~3~ aq., on a 0.2 mmol scale and using 1.2 equiv. of **2**; with \[**1a**\]~0~ = 0.2 M. After 24 hours, the 4,5′-addition was quenched by filtration through a pad of silica. Upon evaporation of the solvent, the crude residue was dissolved in 2 mL of AcOEt and 10 mol% of AgNO~3~ was added.

^*b*^Yield of the isolated products **5** (diastereomeric mixture).

^*c*^Diastereomeric ratio determined by ^1^H NMR analysis of the crude mixture upon cycloisomerisation.

^*d*^Enantiomeric excess determined by HPLC analysis on chiral stationary phases.

^*e*^The absolute configuration of **5a** was unambiguously inferred by X-ray analysis, see [@cit18].

^*f*^Reactions were performed at --10 °C using 1.5 mol% of catalyst.

The relative and absolute configuration of products **4h** and **5a** were unambiguously inferred by anomalous dispersion X-ray crystallographic analysis.[@cit18]

Conclusions
===========

In conclusion, we have developed an operationally simple, two-step process to access a variety of stereochemically dense 2,3-furan fused carbocycles bearing adjacent quaternary[@cit19] and tertiary stereocentres. The salient feature of our study is that complementary organocatalytic systems, both using natural cinchona-derived catalysts, have been identified, which ensure highly selective access to the full matrix of all possible stereoisomeric products at will.
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[^1]: †Electronic supplementary information (ESI) available: Complete experimental procedures and full compound characterisation, including HPLC traces and NMR spectra (PDF). CCDC [1046068](1046068) and [1046069](1046069). For ESI and crystallographic data in CIF or other electronic format see DOI: [10.1039/c5sc01052g](10.1039/c5sc01052g)
